CBD explained by the World Health Organization (WHO)
Oct 24, 2021
A compound found in the cannabis plant is not harmful, has health benefits, and does not have abuse potential, stated by experts at the World Health Organization (WHO). The WHO's Expert Committee on Drug Dependence focused on cannabidiol, or CBD, one of the naturally occurring cannabinoids found in cannabis plants.⠀
After reviewing evidence from animal and human studies, the committee concludes that "In humans, CBD exhibits no effects indicative of any abuse or dependence potential."⠀
Cannabidiol—CBD—is a cannabis compound, extracted from marijuana or hemp, that has significant medical benefits, but does not make people feel “high” and can actually counteract the psychoactivity of THC. The fact that CBD is non-psychoactive makes it an appealing option for patients looking for relief from a variety of ailments.⠀
The experts also say that CBD might be able to treat epilepsy (where most research has focused). Other conditions it might treat are Alzheimer's disease, Parkinson's, anxiety, depression, ptsd, and other maladies. CBD may ease inflammation, provide antioxidants, and relieve pain. Based on its research, the committee concluded that current information does not call for scheduling of the drug.⠀
Scientific and clinical research—much of it sponsored by the US government via the National Institutes of Health (NIH) underscores CBD’s potential as a treatment for a wide range of conditions, including arthritis, diabetes, alcoholism, MS, chronic pain, schizophrenia, PTSD, depression, antibiotic-resistant infections, epilepsy, and other neurological disorders. CBD has demonstrable neuroprotective and neurogenic effects, and its anti-cancer properties are currently being investigated at several academic research centers in the United States and elsewhere.⠀
FDA Disclaimers apply to our products. This information is for general purposes only.